Status:
COMPLETED
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess potential interactions between intravenous (i.v.) cocaine and atomoxetine (Strattera) administered orally in four escalating doses.
Eligibility Criteria
Inclusion
- 18-45 years of age who are not seeking treatment at the time of the study
- Must be able to provide written informed consent
- Must be within 20 percent of ideal body weight and weigh at least 45 kg
- Must meet DSM0IV diagnostic criteria for cocaine abuse or dependence
- Must currently be using cocaine as confirmed by a positive BE
- If female and of child bearing potential, must agree to the use of birth control
Exclusion
- \- please contact the site directly for more information
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00265265
Start Date
August 1 2005
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uniformed Services University of Health Science
Bethesda, Maryland, United States, 20814 4799